Related Experiment Video
Updated: Jun 16, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes
Katrin Zaragoza1, Valérie Bégay, Anja Schuetz
1Max Delbrueck Center for Molecular Medicine, Tumorigenesis and Cell Differentiation, Robert-Roessle-Str.10, 13125 Berlin, Germany.
CCAAT/enhancer-binding protein alpha (C/EBPalpha) regulates cell growth and differentiation. A mutant C/EBPalpha impairs these processes by interacting with E2F/DP, disrupting normal cell function and potentially leading to leukemia.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Biology
Background:
- CCAAT/enhancer-binding protein alpha (C/EBPalpha) is a crucial transcription factor controlling cell proliferation and differentiation across various cell types.
- C/EBPalpha inhibits proliferation by repressing E2F-regulated genes and promotes differentiation by transactivating lineage-specific genes.
- Mutations in C/EBPalpha, particularly C-terminal bZIP mutations like the BRM2 mutant, are implicated in acute myeloid leukemogenesis.
Purpose of the Study:
- To investigate the molecular mechanism by which the myeloproliferative C/EBPalpha BRM2 mutant contributes to leukemogenesis.
- To elucidate the interaction between C/EBPalpha, E2F/DP, and pocket proteins in regulating cell proliferation and differentiation.
- To understand how C/EBPalpha-E2F/DP interaction affects C/EBPalpha DNA binding and transactivation potential.
Main Methods:
- Co-immunoprecipitation assays to study protein-protein interactions.
- Electrophoretic mobility shift assays (EMSAs) to assess DNA binding affinity.
- Reporter gene assays to measure transactivation potential.
- Analysis of cell differentiation and proliferation markers in the presence of wild-type and mutant C/EBPalpha.
Main Results:
- C/EBPalpha directly interacts with the E2F dimerization partner (DP) independently of pocket proteins.
- This C/EBPalpha-E2F/DP interaction inhibits C/EBPalpha binding to its DNA targets and its transactivation capabilities.
- The BRM2 mutant shows enhanced interaction with E2F/DP, reduced DNA binding affinity, but retains differentiation potential when E2F/DP levels are low.
Conclusions:
- A tripartite balance involving C/EBPalpha, E2F/DP, and pocket proteins is critical for controlling cell proliferation, differentiation, and preventing tumorigenesis.
- Disruption of this balance, as seen with the BRM2 mutant, can lead to impaired differentiation and uncontrolled proliferation, contributing to leukemogenesis.
- Targeting the C/EBPalpha-E2F/DP interaction may offer therapeutic strategies for myeloid leukemias associated with C/EBPalpha mutations.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Master Transcription Regulators
Co-activators and Co-repressors
Co-activators and Co-repressors

